Nuclear Medicine Sales Market PowerPoint PPT Presentations

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Nuclear Medicine for these regions, from 2012 to 2023 (forecast)

The nuclear medicine market consists of sales of nuclear medicine and related products by entities (organizations, sole traders, and partnerships) that are used to assess the health of organs or tissue or to identify and remove any diseased or damaged organs or tissue. Nuclear medicine refers to a specialised area of radiology that uses radioactive material inside the body to inspect the overall health condition of the concerned patient. This branch of radiology is frequently used to identify and treat abnormalities that first appear very early in the course of a disease, such as thyroid cancer.

The nuclear medicine market consists of sales of nuclear medicine and related products by entities (organizations, sole traders, and partnerships) that are used to assess the health of organs or tissue or to identify and remove any diseased or damaged organs or tissue. Nuclear medicine refers to a specialised area of radiology that uses radioactive material inside the body to inspect the overall health condition of the concerned patient. This branch of radiology is frequently used to identify and treat abnormalities that first appear very early in the course of a disease, such as thyroid cancer.

The Nuclear Medicine Equipment Market size is projected to reach $2.6 billion by 2026, with a CAGR of 4.6% during the forecast period 2021-2026.

Europe Nuclear Medicine Equipment Market grow at a CAGR of approximately 11.9% in the forecast period of 2021 to 2028. Nuclear medicine equipment refer to equipment which examine various processes such as expression of cell receptors in normal cells and abnormal cells, tissue blood flow, apoptosis, neurotransmitter activity, cell trafficking, metabolism and homing. These equipment are utilized for drug development and diagnosing numerous ailments and diseases such as neurological diseases, cancer and cardiovascular disorders. They are even useful in the area of unidentifiable structural alteration when paired with computed tomography (CT). Get Full Access of Report @ https://www.databridgemarketresearch.com/reports/europe-nuclear-medicine-equipment-market

The global Radiopharmaceuticals/Nuclear Medicine Market was valued at US$ 5605 Million in 2022 and is anticipated to grow at US$ 9327 Million by 2029 recording a CAGR of 9.3% during the forecast period 2023-2029. Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=17441

The global nuclear medicine equipment market size reached US$ 3.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.2 Billion by 2032, exhibiting a growth rate (CAGR) of 5.8% during 2024-2032. More Info:- https://www.imarcgroup.com/nuclear-medicine-equipment-market

The prostate cancer nuclear medicine diagnostics market is expected to grow from US$ 720.12 million in 2022 to US$ 1,315.66 million by 2028. It is estimated to grow at a CAGR of 10.6% from 2022 to 2028.

Nuclear Medicine Equipment Market size is estimated to reach $2.3 billion by 2027, growing at a CAGR of 3.9% during the forecast period 2022-2027.

The Nuclear Medicine Equipment Market size is projected to reach $2.6 billion by 2026, with a CAGR of 4.6% during the forecast period 2021-2026. Nuclear medicine involves the use of radioactive substances called radiotracers used in the diagnosis and treatment of illnesses such as cardiovascular diseases, neurological diseases, cancers, and so on. The radiotracers are injected, inhaled, or swallowed by the patient and then emit gamma radiation that can be detected by nuclear imaging devices.

This Report provided by GrandResearchStore is about , sales (consumption) of Nuclear Medicine Equipment in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering Philips Healthcare GE Healthcare Siemens Healthcare Digirad Corporation Mediso Medical Imaging Systems Toshiba Medical Systems

This report studies the global market size of Radiopharmaceuticals in Nuclear Medicine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Radiopharmaceuticals in Nuclear Medicine in these regions.

Global Nuclear Medicine Equipment Market Research Report 2017 http://www.gosreports.com/global-nuclear-medicine-equipment-market-research-report-2017/

Global Nuclear Medicine Equipment Market,By Product (Single-Photon Emission Computed Tomography (SPECT) (Standalone, Hybrid), Planar Scintigraphy, Hybrid Pet), by Application (Oncology, Cardiology, Neurology), by End-user (Hospitals, Imaging Centers, Academic & Research Centers), by Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) – Industry Trends and Forecast to 2024http://databridgemarketresearch.com/reports/global-nuclear-medicine-equipment-market/

The Radiopharmaceutical/Nuclear Medicine Market Report offers a complete picture of industry trends and factors along with quantitative data based on historical data and from various sources. Apart from this, the report also provides the market outlook, growth, share, size, opportunity and forecast during 2019-2025. Further, the report focuses on competitive landscape including company profiles of leading key players along with industry demand, future capacities, key mergers & acquisitions, financial overview in the global market of radiopharmaceutical/nuclear medicine.

This report studies the European nuclear medicine/radiopharmaceuticals market for the forecast period of 2015 to 2020. This market is expected to reach $1.62 Billion by 2020 from $1.09 Billion in 2015, at a CAGR of 8.2% during the forecast period (2015 to 2020).

Nuclear Medicine / Radiopharmaceuticals Market report segmented the global market by Applications (Cancer/Oncology, Cardiac), By Stable Isotopes (Deuterium, C-13), [SPECT/PET Radioisotopes (Technetium, F-18)] & by Geography – Forecasting - 2017

[No of pages - 346 ] Browse 142 market tables and 44 figures/charts on Nuclear Medicine / Radiopharmaceuticals Market report segmented the global market by Applications (Cancer/Oncology, Cardiac), By Stable Isotopes (Deuterium, C-13),[SPECT/PET Radioisotopes (Technetium, F-18)] & by Geography – Forecasting - 2017

This report studies the Asia-Pacific nuclear medicine market over the forecast period of 2012-2017. The Asia-Pacific radiopharmaceutical market was valued at $500.8 million in 2012 and is poised to reach $824.9 million by 2017 at a CAGR of 10.5%. Similar to the global nuclear medicine market, the Asia-Pacific region is also minimizing its dependency on nuclear reactor by introducing hospital-based cyclotron facilities. This paves the way for novel isotopes such as Tl-201, F-18, and Rb-82 to capitalize on opportunities in the growing diagnostics market. Besides the gigantic Tc-99m market, florbetapir F 18 and F18-FDG are gaining popularity through their applications for Alzheimer’s disease and diagnosis of brain tumors. Nihon Medi Physics, Covidien, Fujifilm, and ANSTO contributed more than 75 % to the APAC radiopharmaceuticals market in 2012.

Big Market Research present “Nuclear Medicine Imaging Equipment Industry” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast to 2020. Visit for more info @ http://www.bigmarketresearch.com/global-nuclear-medicine-imaging-equipment-industry-2015-deep-research-report-market The report Global Nuclear Medicine Imaging Equipment Industry 2015 Market Research Report is a thorough study on the industry insights and market dynamics, market share and size of the global nuclear medicine imaging equipment industry. The report is prepared by professional market analysts using unique research methodology and with the help of invaluable inputs by industry experts.

The radioisotope and stable isotope markets have been segmented according to the type of isotope, and a pplications.Both of these markets are broken down into segments and sub-segments, providing exhaustive value analysis for the years 2010, 2011, 2012, and forecast to 2017. Each market is comprehensively analyzed at a granular level by country (Germany, France, Italy, Spain, U.K., Russia, and Rest of Europe) to provide in-depth information on the European scenario.

In the past few years, more efficient therapeutic nuclear medicines have been launched, which have shown positive results for the treatment of various types of cancer. For instance, the launch of Xofigo (Radium-223) by Bayer for the treatment of prostate cancer and the launch of Lutathera (Lutetium-177) for the treatment of neuroblastoma and synovitis has created growth opportunities for the therapeutic nuclear medicines market over the forecast period.

The global nuclear medicine imaging market is expected to reach USD 5.13 Billion by 2027, according to a new report by Reports and Data.

Pegasi Media Group can help you reach-out top Nuclear Medicine email list list with your marketing and promotional messages. Our team understands the importance of healthcare marketing and we can help you maximize the results of your marketing dollars. please call 1-302-803-5211 or Email us at: sales@pegasimediagroup.com Operating hours are: Monday - Friday, 6am - 5pm (Pacific Time)

Global B2B Contact can help you reach-out top Nuclear Medicine Director email list with your marketing and promotional messages. Our team understands the importance of healthcare marketing and we can help you maximize the results of your marketing dollars.

The radiopharmaceuticals market is projected to reach US$ 13,818.17 million by 2028 from US$ 7,550.74 million in 2021; it is expected to grow at a CAGR of 9.0% from 2021 to 2028.

Press Release on “Nuclear Medicine/Radiopharmaceuticals market- Size, Share, Trends Forecast 2022” added by Research Trades to its database. In this report, the global Nuclear Medicine/Radiopharmaceuticals market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Get Sample Copy of this report @ http://www.researchtrades.com/request-sample/1086022

This market is expected to reach USD 2.13 Billion by 2020 from USD 1.78 Billion in 2015, and is poised to grow at a CAGR of 3.6% during the forecast period.

The nuclear medicine market is projected to reach USD 5.26 billion by 2023 from USD 3.95 billion in 2018. Factors such as the growing incidence and prevalence of cancer and cardiac ailments and initiatives to lessen the demand-supply gap of Mo-99, are driving market growth.

This market is expected to reach $1.62 Billion by 2020 from $1.09 Billion in 2015, at a CAGR of 8.2% during the forecast period (2015 to 2020).

Analysis of major geographic regions, including North America, Europe, Japan and Latin America. Discussion of trends in X-ray, ultrasound, MRI, CT, nuclear medicine, PET, PACS and other technologies. Read The Complete Report On : http://www.bigmarketresearch.com/2015-global-diagnostic-imaging-market

According to #TechSci Research report, Global Nuclear Imaging Equipment Market stood at USD4054.46 million in 2020 and is expected to grow at a CAGR of 6.51% by 2026. Gain More Insight: https://bit.ly/3v29zB4 Get Sample Report: https://bit.ly/3KdYyVJ Press Release: https://bit.ly/3LGMv3y Website: https://www.techsciresearch.com/ Market Research News: https://techsciblog.com/

To Get sample Brochure now@ http://tinyurl.com/hwdbkw6 A vibration sensor which is also known as vibration transducer converts received vibrations into an electrical equivalent output. These sensors have a variety of applications in different fields such as industries, medicine, electronics and so on, thus it is boosting the Vibration Sensor Market.

Radiation dose management includes information of radiation dose recording software, real-time staff dose monitoring, regulatory compliance and technology to reduce dose, including interactive reconstruction software.

The advent of hybrid imaging has enabled PET/CT imaging to undergo explosive growth. For more details : http://goo.gl/BOm3Ax

Goldstein Research analyst forecast the Metabolomics market size is set to reach USD 2.1 billion by 2024, at a CAGR of 11.3% over the forecast years. With increasing importance being placed on health and safety related aspects of food, metabolomics can potentially be a valuable tool to monitor and improve the quality of what we consume.

Our Email List can be used in various ways such as market research, generating a sales lead, job seeking, telemarketing, building a business directory, business analysis, and other b2b purposes. targeted mailing list, buy targeted email list, Advertising Agencies Database, automobile industry email list. info@globalb2bcontacts.com http://www.globalb2bcontacts.com https://globalb2bcontacts.com/email-database.html

Our specialized Nuclear Medicine Director Email list can assure high delivery of your campaigns through the most preferred marketing channels

The report covers the major unsaturated polyester resin (UPR) markets including Orthophthalic, Isophthalic, and DCPD resins. It further divides the market on the basis of types, industry verticals, and geography. The report analyses the market for unsaturated polyester resins with respect to drivers, opportunities, and winning imperatives related to the industry.

The global nuclear imaging devices and equipment market was valued at about $3.3 billion in 2018 and is expected to grow to $3.76 billion at a CAGR of 3.3% through 2022. Read more at http://bit.ly/352ljXi

marketreportslibrary.com has released a new "North American Nuclear Medicine or Radiopharmaceuticals Market" report for the upcoming year, that includes major growth is projected over the forecasting period.

According to #TechSci Research report, Global Precision Medicine Market, was valued USD66.85 billion in 2020 and is expected to reach USD125.67 billion, growing at CAGR of 10.65% during the forecast period. Gain More Insight: https://bit.ly/3Df5kr2 Get Sample Report: https://bit.ly/3kneqJG Website: https://www.techsciresearch.com/ Market Research News: https://techsciblog.com/

Middle East and Africa immunoassay-gamma counters market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 3.9% in the forecast period of 2021 to 2028 and is expected to reach USD 2.51 million by 2028. Increasing prevalence of chronic diseases, and increasing adoption of nuclear medicine are the major drivers which propelled the demand of the market in the forecast period.

Middle East and Africa immunoassay-gamma counters market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 3.9% in the forecast period of 2021 to 2028 and is expected to reach USD 2.51 million by 2028. Increasing prevalence of chronic diseases, and increasing adoption of nuclear medicine are the major drivers which propelled the demand of the market in the forecast period.

Nuclear Medicine / Radiopharmaceuticals Market report segmented the global market by Applications (Cancer/Oncology, Cardiac), By Stable Isotopes (Deuterium, C-13), [SPECT/PET Radioisotopes (Technetium, F-18)] & by Geography – Forecasting - 2017

LifeScienceIndustryResearch.com adds “Nuclear Imaging- PET and SPECT Equipment – Global Analysis and Market Forecasts” to its store. This report examines how new technologies can emerge in the face of economic pressures that may affect the demand for nuclear imaging, and how healthcare reforms are impacting nuclear medicine.

Big Market Research present “Nuclear Medicine Imaging Equipment Industry” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast to 2020. Visit for more info @ http://www.bigmarketresearch.com/global-veterinary-drug-industry-2015-deep-research-report-market Global Veterinary Drug Industry 2015 Market Research Report is an outcome of critical analysis of veterinary drug market business performance. Research analysts conducting the study engages concise yet straightforward questionnaires to highlight the key definitions, classifications and applications of the industry.

Prominently driven by the growth of medical tourism sector and increasing expanse of diagnostics, the global revenue of medical physics market will reportedly thrive at a healthy over-6% CAGR during 2018-2028. Growing adoption of nuclear medicine has also been cited as an important factor responsible for a positive growth outlook anticipated for medical physics market.

Prediction Markets Leighton Vaughan Williams Professor of Economics and Finance Nottingham Business School Nottingham Trent University Leighton.Vaughan-Williams@ntu.ac.uk

Global Radiopharmaceuticals Industry Analysis http://www.reportsnreports.com/reports/274695-global-radiopharmaceuticals-market-insight.html . The new innovations in nuclear medicine to target coronary heart disease, Alzheimer’s disease, breast cancer, and bone metastasis would be the major drivers of the diagnostic radiopharmaceuticals market in the future. The other segment of the market is the therapeutic segment, which accounts for the remaining 10%.

According to the Regional Research Reports, the global Perfusion Radiology market is expected to project a double-digit CAGR during the forecast period (2024-2033). The report provides an in-depth analysis of the market size (Euro/USD Million) and volume (units/tons). This analysis has been systematically compiled through an exhaustive examination of the business operations and product portfolios of competitors entities that are actively engaged in the global market.

The Global ePharmacy Market size is expected to reach $167.6 billion by 2027, rising at a market growth of 16.4% CAGR during the forecast period. ePharmacy refers to the online sales of non-prescription and prescription drugs like conventional pharmacies. These pharmacies take online orders and deliver them to the customers in a stipulated time frame.

Medical Radiation Shielding Market, By Products (Shields, Barriers, Booths, X-ray rooms, Sheet Lead, Lead Bricks, Lead Curtains, Lead Lined Doors & Windows, Lead Glass, High Density Concrete Blocks, Lead Acrylic, MRI Shielding Products), Solution (Radiation Therapy Shielding, Diagnostic Shielding) , End-User (Hospitals, Diagnostic Centers) – Global Revenue, Trends, Growth, Share, Size, and Forecast To 2022

According to the latest research report by IMARC Group, The global alpha emitter market size reached US$ 1,476.8 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 10,975.8 Million by 2032, exhibiting a growth rate (CAGR) of 24.22% during 2024-2032. More Info:- https://www.imarcgroup.com/alpha-emitter-market

Nuclear Radiology is a method of producing images by detecting radiation from different parts of the body after a radioactive tracer material is administered. The images are recorded on computer and on film. The nuclear imaging physician interprets the images to make a diagnosis.

According to the latest research report by IMARC Group, The global hydrazine market size reached US$ 511.8 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 890.3 Million by 2032, exhibiting a growth rate (CAGR) of 6.2% during 2024-2032. More Info:- https://www.imarcgroup.com/hydrazine-market